Skip to main content
. 2021 Nov 5;2:759634. doi: 10.3389/fpain.2021.759634

Table 1.

Patient cohort descriptive statistics and clinical survey measures.

Control IBS/FAP
Total patients 3 19
Age 13 (±2.08) 14.26 (±0.73)
M:F 33% 47%
Diagnosis
IBS-C - 5.26%
IBS-D - 47.37%
IBS-M - 10.53%
FAP - 36.84%
Pain-related measures
CSI-24 8.67 (±7.69) 27.37 (±2.84)
PCS-C 13 (±9.29) 26.68 (±2.64)
   Rumin 7 (±3.79) 11.05 (±0.89)
   Magnf 1.33 (±1.33) 4.79 (±0.72)
   Helpless 4.67 (±4.67) 10.84 (±1.29)
Pain measures
PBI 0 (±0) 12.37 (±1.10)
APPT
   Tot BSA 0 (±0) 516.16 (±107.50)
   Tot # areas 0 (±0) 2.68 (±0.36)
   Abd BSA 0 (±0) 301.11 (±41.76)
   Abd # areas 0 (±0) 1.79 (±0.12)
PFSD
# of days 0 (±0) 10.56 (±0.86)
Lvl pain 0 (±0) 5.86 (±0.41)
Hrs pain 0 (±0) 2.63 (±0.34)
Worst pain 0 (±0) 7.71 (±0.33)
Hrs worst pain 0 (±0) 1.79 (±0.25)
Comp-worst 0 (±0) 14.5 (±2.56)